Angiotensin H modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts. The renin-angiotensin system seems to play an important role in the pathogenesis of renal interstitial fibrosis. However, the potential direct effects of angiotensin It (Ang II) on cultured renal flbroblasts have been little studied. We have observed that rat renal interstitial fibroblasts (NRK 49F cell line) possess AT1 receptors coupled to intracellular calcium mobilization. Exposure of these cells to Ang II induced several short and long growth-related metabolic events mediated by the AT1 receptor, including c-fos gene expression, changes in cell cycle and cell proliferation. Activation of interstitial fibroblasts by Ang II could also contribute to extracellular matrix accumulation. Stimulation with Ang II increased mRNA expression of TGF-131, fibronectin and type I collagen. In fact, Ang II enhanced fibronectin production via AT1 receptors by a process depending on autocrine TGF-p secretion. The mechanism of some Ang II actions (calcium mobilization and fibronectin production) depended on protein kinase C and tyrosine kinase activation. We further investigated whether renal fibroblasts could express some components of the renin-angiotensin system. These cells constitutively expressed the angiotensinogen gene that was up-regulated by Ang II. Collectively, these results indicate that in renal interstitial fibroblasts Ang II causes hyperplasia and extracellular matrix production via the AT1 receptor. Ang II may initiate a positive feedback regulation of fibroblasts growth, inducing the expression of TGF-J31 and angiotensinogen genes. Ang II, acting directly on interstitial fibroblasts, may be implicated in the pathogenesis of renal fibrosis.
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Fibroblasts are the main effector cells of renal interstitial fibrosis. Under normal conditions only a small proportion of these cells participate in the synthesis and deposition of matrix proteins, mainly type I collagen [1] . However, in pathological conditions, fibroblasts proliferate, migrate and synthesize growth factors and matrix proteins [2] . The development of interstitial fibrosis has been attributed to the release of cytokines by infiltrating mononuclear cells and tubular interstitial cells. These cytokines, acting on fibroblasts, could induce proliferation, recruitment of mononuclear cells and extracellular matrix synthesis [3, 4] . nuclear cell recruitment, proliferation of interstitial cells, and deposition of matrix proteins leading to renal interstitial fibrosis [16, 17] . However, a direct effect of Ang II on renal interstitial fibroblasts independently from secondary hemodynamic actions, which could explain the above-described processes, has not been studied.
Angiotensin II may act as a growth factor for several renal cells.
In mesangial cells and tubular epithelial cells this peptide promotes growth changes and synthesis of extracellular matrix proteins. Some of these effects seem to be mediated by the release of growth factors, such as transforming growth factor-/3 (TGF-13) [7, 18]. TGF-/3 plays an important role in the pathogenesis of renal diseases [19] and has widespread effects on the turnover of extracellular matrix proteins [20] . In this work we have studied the potential effect of Aiig II on growth-related cellular events in renal interstitial fibroblasts. To test this hypothesis, we first characterized whether renal fibroblasts express Ang II receptors and the intracellular signaling evoked by their stimulation. Secondly, we evaluated whether Ang II regulates fibroblast proliferation and the synthesis of extracellular matrix and TGF-13, as well as the mechanisms and the receptor type involved in these phenomena. Finally, we tested whether these cells could contribute to local Ang II generation focusing on angiotensinogen mRNA expression.
METHODS

Materials
All culture reagents were purchased from Gibco BRL (Paisley, Scotland, UK). Ang 11 was obtained from Calbiochem. Dup753 (ATI receptor antagonist) was provided by Dupont (Madrid, antibody and recombinant human TGF-/31 were obtained from Immugenex (Los Angeles, CA, USA). The rest of chemicals employed were from Sigma (St Louis, MO, USA).
Cell cultures
The cell line NRK 49F (ATCC:CRL157O; American Type Culture Collection, Rockville, MD; USA) is derived from rat kidney fibroblasts. Cells were grown in RPMI with 5% FCS (Gibco) at 37°C in the presence of 5% CO2.
Determination of angiotensin II receptors
Receptor binding studies were performed on subconfluent monolayers of fibroblasts, cultured in 12-well plates, using 125J [Sar',11e5]Ang II. Cells were maintain for 18 hours in serum-free RPMJ, and after, in RPM! with 0.5% (wt/vol) of BSA for one hour. Then cells were incubated with '251[Sar1,11e8]Ang 11(0.1 nM). Competition studies were performed using either Ang II or the receptor subtype-specific nonpeptide antagonist [22] DUP753 (AT1 specific) or PD123177 (AT2 specific) at various concentrations (102 to io M). Nonspecific binding was determined in the presence of 1000-fold excess of unlabeled Ang II and was less than 10% of the total cell bound radioactivity. Binding parameters (Kd and number sites/cells) were calculated using the Instat program. After incubation for three hours at 4°C (equilibrium binding achieved), cells were washed twice with ice-cold phosphate saline (PBS) to remove unbound compound. Then cells were solubilized in 1 M NaOH/0.1% Triton X-100. Radioactivity in cell lysates was determined in a gamma counter. Specific binding was calculated as the difference between total and nonspecific ligand bound.
Measurement of intracellular free calcium
Measurement of calcium mobilization was made as previously described [231. Monolayer cells grown on 13 mm diameter crystal coverslips were incubated in serum-free medium during the last 18 hours before the experiment. The cells were then washed and loaded with the fluorescence Ca2 indicator fura-2 acetometoxy ester (2 jIM) in RPMI-HEPES for 60 minutes at 37°C, and incubated again for 30 minutes in a fura-2-free medium for intracellular dye cleavage. Cells were then rinsed twice with Krebs-Hensleit-HEPES buffer (KHH) (130 mtvi NaCl, 5.3 mM KC1, 1 mM MgSO4, 2 ifiM CaC12, 1.2 mi NaH2PO4, 20 mM HEPES, 5.5 mrvi glucose, and 0.5% BSA, pH 7.3), and coverslips were mounted in a quartz cuvette with 1 ml of KHH buffer at 37°C. Substances prewarmed in KHH buffer were added directly to the cuvette. Changes in intracellular calcium ([Ca2]) were continuously monitored by recording changes in the fluorescence ratio at 510 nm, with the excitation at 340/380 nm in a spectrofluorometer at 37°C (model LS-50; Perkin-Elmer Corp., Norwalk, CT, USA). In some experiments, extracellular Ca2 was depleted from the medium by addition of 3 to 5 msi EGTA just before the fluorescence analysis. In these experiments, after addition of Ang II (10 M) and when baseline returned to control levels, Ca2 was replaced in the medium to 2 m of final concentration. To characterize intracellular signal systems, cells were preincubated with the protein kinase C (PKC) inhibitor, staurosporine (10-6 M, 30 mm), or the tyrosine kinase inhibitor, genistein (10-s M, 60 mm). To determine the angiotensin receptor type involved in calcium response, cells were preincubated with DUP753 (AT1 specific; 10 M, 30 mm) or PD123177 (AT2 specific; i0 M, 30 mm).
Cell-cycle analysis by fluorescence-activated cell sorting For determination of cell size and DNA content, subconfluent cells grown in 75 cm2 petri dishes were incubated in a serum-free medium for 48 hours to make them quiescent. Then cells were incubated during 24 hours with Ang II (10-v M) and 10% FCS as the positive control. At the end of the incubation period, the cells were washed three times with PBS and trypsin. After centrifugation, the cellular pellet was treated with 100 jIg/ml ribonuclease A and DNA was stained with 100 jtg/ml propidium iodide in 0.005% Nonidet P-40. The stained specimen was kept in the dark at 4°C before flow cytometry. Cells were sieved to remove dead cells and/or cellular debris. Data were analyzed with the EPICS-C flow cytometer (Coulter, Hialeah, FL, USA) using the PARA-1 program [241 and represented as either contour plots or histograms. The percentage of cells in the Go, S and G2 + M phases, mean channel number and coefficient of variance (CV) for relative size and DNA content were obtained from histograms after computer analysis.
Measurement of cellular proliferation
The effect of Ang II on cell proliferation was determined by After the incubation period, cells were washed with PBS and fixed. Cells were stained with methylene blue in 0.01 M Borate buffer. The absorbance was measured at 650 nm in a microplate photometer.
RNA isolation, Northern blot and PCR assays
The expression of transcripts for AT1 receptor, c-fos, extracellular matrix proteins and TGF-/31 was determined using Northern blot analysis. The angiotensinogen gene expression was studied by a semiquantitative RT-PCR technique.
Northern blot analysis. Quiescent confluent fibroblasts, grown in 75 cm2 petri dishes, were stimulated in a serum-free medium. After the incubation period, total RNA was extracted by the Chomczynski and Sacchi method [26] and quantitated by absorbance at 260 nm. Northern blot analysis was performed as previously described [27] . The eDNA probes used were: c-fos (ATCC#), (cil)I (Hf677) and (al)IV (pCVIV-1-PE16) collagens, 28S, rat FN (SR270) and murine TGF-/31, obtained as previously described [27] , and labeled with a-[32P]dCTP. The rihoprobe of the AT1 receptor (kindly provided by Dr. M. Martincz-Maldonado, originally cloned by Murphy et al [28] ) was used as the antisense cRNA from linearized plasmid with Hindill using SP6 promotor and labeled with a-[32P]-ATP. Blots were prehybridized for four hours at 42°C in hybridization solution (50% formamide, 1% SDS, 5 x SSC, lx Denhardt's solution, 0.1 mg/mI denatured salmon sperm DNA and 50 m sodium phosphate buffer, pH 6.5) and hybridization was carried out at 42°C overnight with 20% dextran sulfate and [ci-32P]-denatured probe. The filters were washed using a 2 x SSC, 0.1% SDS, at room temperature for 30 minutes and then twice with 0.2 >< SSC, 0.1% SDS, at 55°C for 15 minutes. For the AT1 receptor, prehybridization and hybridization were carried out at 60°C in modified solution (hybridization mixture with 8X Denhardt's solution and 1 mai EDTA), and the filters were washed first at 65°C and finally at 70°C, in the same conditions as described above. Autoradiography was performed using standard methods.
Reverse transcription and semiquantitative PCR analysis. Total RNA was reverse transcribed to single-stranded eDNA by incubation with a reverse transcription mixture (5 mvt MgCl2, 10 mM Tris-HCI pH 8.8, 50 mivi KCI, 0.1% Triton X-100, 1 mM dNTPs mixture, 20 U rRNAsin ribonuclease inhibitor, 15 U AMV reverse transcriptase and 50 ng random primers) at 42°C for 30 minutes following the instructions of the manufacturer (Promega). PCR analysis for angiotensinogen and Glyceraldehyde 3'-phosphate dehydrogenase (G3PDH) was conducted in the following conditions (1 mm at 63°154°C, respectively, to allow annealing of the primers, 3 mm at 72°C for primer extension, and I mm at 94°C to denature the double-stranded DNA). The following primers were used for rat angiotensinogen [291: (antisense) 5'-CCAGCCGG-GAGGTGCAGT-3' and (sense) 5'-TTCAGGCCAAGACCT-CCC-3', that yielded products of 308 base-pair. G3PDH was used as an internal control and the following primers were used [30] : (antisense) 5'-ATACTGTTAC1TATACCGATG-3' and (sense) 5 '-AATGCATCCTGCACCACCAA-3' that yielded products of 515 bp. Both amplifications were done for 20, 30, 35, and 40 cycles in order to establish the linearity of the reaction. In all experiments, the presence of possible contaminants was checked by control reactions in which amplification was carried out in complete reaction mixture lacking template DNA or with RNA samples from RT reactions done in the absence of AMV reverse transcriptase. The DNA products from the PCR reactions were analyzed on a 1.5% agarose gel or a 4% polyacrylamide/urea gel in Tris-borate EDTA buffer. The gels were dried and exposed for autoradiography.
Autoradiograms were scanned using the Image Quant densitometer (Molecular Dynamics, Sunnyvale, CA, USA). Results were expressed as arbitrary densitometric units relative to 28S intensity bands (Northern blot) and G3PDH (RT-PCR).
Determination of fibronectin synthesis
New fibronectin (FN) synthesis was measured by metabolic labeling with [35S]-Methionine and immunoprecipitation with anti-FN antibodies [31] . Quiescent cells grown in 24 well plates, were incubated in methionine-free culture medium RPMI with 20 jiCi/ml of [35S]-methioninc and stimuli. After 24 hours, medium was collected and cells were lysed with extraction buffer (50 mM Tris-HCI, 150 mrvi NaC1, 0.5% Triton X-100, 2 mrvi PMSF, 2 mM EDTA and 5 mM NEM, p11 7.4). Aliquots of the supernatants (diluted 1:10 in extraction buffer) and cell lysates were immunoprecipitated with an excess of anti-FN antibody (50 tg) for 16 to 18 hours at 4°C. After this incubation, immune complexes were recovered by addition of protein A-Sepharose beads (Pharmacia, Uppsala, Sweden), and incubated for one additional hour. Beads were washed in extraction buffer. FN was released by heating at 100°C for five minutes in electrophoresis sample buffer and analyzed under denaturing conditions in 7.5% SDS-polyacrylamide gels. The gels were handled by fluorography techniques and autoradiography was performed by standard methods. In order to normalize FN production to cell number, samples aliquots (20 1.d) of cell lysates were taken for determination of DNA content. As a negative control for immunoprecipitation, isotopic normal rabbit IgG (30 jxg/ml) was used.
For experiments with Ang II receptor antagonists, cells were preincubated with DUP753 ( 
Statistical analysis
Results are expressed as the mean SEM. Significance was established using a Student's t-test and analysis of variance. Differences were considered significant if the P value was less than 0.05.
RESULTS
Renal interstitial fibroblasts possess AT1 receptors
We first examined whether rat renal interstitial fibroblasts (NRK cell line) express Ang II receptors. Binding studies were Ang II indicated the existence of a specific binding in renal interstitial fibroblasts with a K of 0.23 nM and around 54000 sites/cell (Fig. 1A) . Ang II receptors have been described in medullary interstitial cells [32] and in rabbit renal interstitial fibroblasts [33] . In interstitial mice fibroblasts (TFB cell line, [34] ), we also determined the Ang II binding sites showing similar results to those described for rat cells (data not shown). Moreover, the affinity of these receptors (Kd of 0.23 nM) in rat renal fibroblasts was similar to that reported for AT1 receptors in fibroblasts of different tissues (cardiac [35, 36] and skin [37]), in vascular smooth muscle cells [38] and mesangial cells [39] .
To determine the receptor subtype present in renal fibroblasts, competition studies were made in the presence of two Ang II specific nonpeptidic receptor antagonists (DUP753, AT1 receptor antagonist and PD123177, AT2 receptor antagonist). Fibroblasts were incubated with '25l-[Sar1,11e8]Ang II and increasing concentrations of DUP7S3 and PD123177 for three hours at 7°C (Fig.   1A ). The AT1 receptor antagonist, DUP753, completely displaced the bound labeled compound. By contrast, the AT2 receptor antagonist, PD123177, did not displace the labeled peptide, though at concentrations higher than 10 M a slight effect was noted. A similar effect has been observed in cardiac fibroblasts, hut it was not clear whether this displacement of the radioligand C) C with high concentrations of PD 123177 was a specific competition or a crossover interaction with the AT1 receptor [35] .
To confirm the presence of AT1 receptors in rat renal interstitial fibroblasts, we determined whether these cells express AT1 receptor mRNA. Total RNA was extracted and analyzed by Northern blot using a riboprobe for AT1 receptor gene cloned from vascular smooth muscle cells [28] . Fibroblasts expressed a transcript of 2.35 kb (Fig. 1B) [40] , tubular epithelial cells [41] and cardiac fibroblasts [361, though the intensity of the response varied among the cell types. Intracellular Ca2 mobilization was determined by continuous monitoring of fluorescence intensity [23] . Cells were loaded with fura-2/AM and the emitted fluorescence in response to Ang II stimulation was measured. Angiotensin II (l0 to 10'' M) evoked a rapid rise in intracellular free calcium. The transient increase in Ca2 was dramatic at higher concentrations of Ang II (Fig. 2) .
The next point of our study was to investigate the mechanism of calcium mobilization in response to Ang II. After chelation of extracellular Ca2 by EGTA, Ang II (10-v M) still elicited an increase in intracellular Ca2 concentrations (Fig. 3) , though the decay to resting levels was faster than in the presence of extracellular Ca2 . When the baseline returned to control levels, Ca2 was replaced in the medium (2 m of final concentration) and an increase in fluorescence was observed, probably due to the influx Time, seconds (Fig. 3) , while the AT2 antagonist did not affect the kinetics of Ca2 mobilization. These results suggest that AT1 receptors presented in renal interstitial fibroblasts are coupled to intracellular calcium mobilization.
Angiotensin II elicits cell hyperplasia, but not hypertrophy, via AT1 receptors Angiotensin II is now considered to be a renal growth factor, however, its effects on cell growth depend on the cell type studied. Ang II induced hypertrophy in tubular epithelial cells [18] , while most authors found a hyperplasic response in mesangial cells [7] . Thus, we were interested in whether Ang IT could modulate the growth in renal interstitial fibroblasts.
By flow cytometry analysis (FACS), we determined the variation of the cell cycle and cell size induced by Ang II. To obtain a quiescent state (G0), cells were maintained for 48 hours in serum-free medium. After treatment with iO M Ang II for 24 hours we observed changes in cellular DNA content that reflected progression through the S phase and mitosis (Fig. 4A) . Ang IT-treated cells presented a high percentage of cells in mitosis (G2/M + S > GJG1; Fig. 4 A, C) . However, the cell size did not vary in response to the Ang II stimulation (control, 20 10; Ang II, 24 11 ; mean channel coefficient of variance, N = 3; P = NS; Fig. 4B ). These data show that when Ang II was added to quiescent (G0) renal fibroblasts, cells entered G1 and progressed to S phase.
To further evaluate the effects of Aug 11 on fibroblast growth, the methylene blue assay was performed. Treatment of growtharrested fibroblasts, in a serum-free medium, with io-M Ang II for 48 hours and 72 hours significantly increased cell proliferation (Fig. 5A ). This effect was dose-dependent between io M to 10 M Ang IT (Fig. 5B) with an optimal concentration of i0 M (167 12% over control, N = 4, P < 0.05, that represents 30% with respect to that observed with 10% FCS, which was used as the positive control). These results suggest that Ang II causes hyperplasia, but not hypertrophy, in renal interstitial fibroblasts, in the conditions of our study.
Next, we examined the Ang II receptor subtype linked to the proliferative response. Preincubation for 30 minutes with the AT1 receptor antagonist DUP753 (10 M), and subsequent stimulation with i0 M Ang II for 48 hours, caused a 70% inhibition in cell proliferation compared to Ang II alone (N = 4, p < 0.05). By contrast, the AT2 receptor antagonist PD123177 (10-s M) did not exert any effect (Fig. 5C ). Neither DUP753 nor PD123177 alone significantly affected cell proliferation in nonstimiilatcd cells ( 5C). These results suggest that Ang Il-induced cell proliferation is mediated by the AT1 receptor.
Angiotensin II induces the expression of growth-related nuclear proto-oncogene c-los
Rapid induction of nuclear proto-oncogenes, such as c-fos, is one of the earliest transcriptional events, and has been associated with cell proliferation, cellular differentiation, and hypertrophy [44] . The c-Jbs protein forms part of the AP-1 complex that binds to the transcription control elements of some genes [45] . in vivo systemic Ang TI-infusion induces c-fos gene expression in the rat kidney [46] . In our study, quiescent renal interstitial fibroblasts were stimulated with iO-M Ang IT for one hour. Afterwards, RNA was isolated and c-fos mRNA expression analyzed by Northern blot. Ang II induced a c-fos transcript of 2.2 Kb, while this gene did not appear in cells in quiescent state (G0) (Fig. 6) . Preincubation with the AT1 receptor antagonist (10 6 M), but not the AT2, abolished Ang TI-induced gene expression (Fig. 6) , suggesting that an AT1 receptor-dependent mechanism is in- Angiotensin II stimulates gene expression of extracellular matrix proteins Many reports have demonstrated that fibroblasts are a major source of extracellular matrix [3] . We initially evaluated the effect of Ang II on the message levels of some matrix proteins.
Stimulation of growth-arrested fibroblasts with Ang II for 18 to 24 hours increased the steady-state mRNA levels of fibronectin (FN) and type I collagen compared to control cells. These effect was dose-dependent, with a maximal response at i0 M Ang 11(2.5-and 1.5-fold increase vs. control, after 18 and 24 hr, respectively).
By contrast, there was no effect on type IV collagen mRNA expression (Fig. 7) .
Angiotensin II increases fibronectin production, via protein kinase C and tyrosine kinases
We assessed the changes in FN production by metabolic labeling with [3551-Methionine and immunoprecipitation with anti-FN antibodies. We have observed that most of the FN produced by renal fibroblasts in normal conditions is secreted to the extracellular medium (around 70% of total FN). Treatment of resting fibroblasts with Ang II (10-v to lO M) for 24 hours caused a significant increase in FN production, with a maximal response at i0 M Ang 11(165 12% increase vs. control 100% 11, N = 9; P < 0.05; Fig. 8A ). In addition, the relationship between soluble and cell-associated fraction was modified showing an increase in cellular FN production (control, 70% soluble vs. 30% cell-associated; Ang II, 47% vs. 53%).
In adult rat cardiac fibroblasts, Ang LI appears to stimulate collagen synthesis by both AT1 and AT2 receptors [471. Therefore, we also evaluated the receptor involved in Ang IT-induced FN production. As shown in Figure 8B , preincubation with the AT1 receptor antagonist DUP753 (106 M), but not with the AT2 receptor antagonist PD123177 (10 M), inhibited Ang IT-induced FN synthesis (DUP753, 95% inhibition vs. Ang II alone, N = 6, P < 0.05; PD123177, 30% inhibition, N = 6, P = NS). Neither DUP753 nor PD123177 alone significantly affected FN synthesis (Fig. 8B) . These results suggest that Ang II regulates matrix accumulation through the AT1 receptor.
To elucidate the mechanism of Ang II effect on FN production, we studied the role of the de novo RNA and protein synthesis. As shown in Figure 8C , pretreatment of cells with actinomycin D (ActD, 50 tgIml) and cycloheximide (CHX, 1 JLg/ml), inhibitors of RNA and protein synthesis, respectively, markedly reduced the amount of FN in control conditions and in response to iO M Ang 11 stimulation (approximately 65% and 70% inhibition vs. control, respectively, N = 3, P < 0.05). These data suggest that FN synthesis induced by Ang IT in renal interstitial fibroblasts is regulated at the transcriptional level.
To clarify the intracellular mechanism of Ang II effects on FN synthesis, we detemiined the role of some signaling events. We wondered whether activation of PKC and tyrosine were involved. Recently, it has been demonstrated that PKC activation can induce FN production [48] . Also, Ang II activates PKC in several cell types [40, 421 . In renal interstitial fibroblasts, treatment with the phorbol ester PMA, an activator of PKC, increased FN production (176 15% increase vs. control, N = 3, P < 0.05; Fig. 8D ). The preincubation with the inhibitor of FKC, staurosporine (Staur., 10_8 M) for one hour, significantly diminished (N = 3, P < 0.05) the Ang Il-induced FN production (Fig. 8D) . Treatment with staurosponne (10 M) did not affect cell viability. These results indicate that Ang 11 increases FN through a PKC dependent pathway.
We also studied the role of tyrosine kinases in fibroblasts in response to Ang IT. Cells were preincubated for 30 minutes with the inhibitor of tyrosine kinase, genistein (Genist, 106 M), before Ang II stimulation. As shown in Figure 8D , tyrosine kinase responsible for the FN production observed upon Ang 11 stimuinhibition caused a significant reduction in FN synthesis (N = 3, lation. P < 0.05). These result suggest that tyrosine phosphorylation may We first examined the effect of Ang II on TGF-f3 expression by participate in Ang TI-induced FN production.
Northern blot analysis. Stimulation of quiescent cells with 10 M Ang II increased the mRNA levels of TGF-J31 with a maximal Role of TGF. in matrix synthesis elicited by angtiotensin H peak at six hours of incubation (2.3-fold; Fig. 9A ). The response Since TGF-J3 is the major cytokine involved in matrix regulation to Ang TI was markedly attenuated by the AT1 receptor antagonist [20] , we tested the hypothesis that endogenous TGF-J3 may he DUP753 (Fig. 98) . Stimulation of renal interstitial fibroblasts with TGF-f3 (50 pM) increased FN production (220 18% increase vs. control, N = 3, P < 0.05), with a higher response than Ang II (Fig.   9C ). In the presence of neutralizing anti-TGFI3 antibody (10 ig/ml), the Ang TI-induced increase in FN production was totally abolished (N = 3, P < 0.05; Fig. 9C ). This effect appears to be specific since normal rabbit IgG failed to inhibit the Ang IIstimulated FN synthesis (not shown). Neither anti-TGFf3 antibody alone nor control IgG had any effect on FN synthesis. This result suggests that endogenous TGF-/3 mediates the Ang II effect on FN synthesis in renal interstitial fibroblasts.
Renal interstitial fibroblasts express angiotensinogen mRNA levels: Regulation by angiotensin II By RT-PCR, we observed that interstitial fibroblasts expressed angiotensinogen mRNA in a constitutive manner (Fig. 10) . This suggests that those cells could participate in the Ang II production in the kidney. It has been shown that Ang II increases angiotensinogen mRNA in rat liver [49] and in cardiac myocytes [50] . We have observed that angiotensinogen gene expression is upregulated by Ang 11(1.6-fold, after 6 hr; Fig. 10 ). This activation was completely inhibited by DUP753, but unaffected by PD123177 (Fig. 10) .
DISCUSSION
In this paper we approached the idea that Ang II may partici- << < cell differentiation [52] , apoptosis [531, thropic effects on vascular smooth muscle cells [54] , mononuclear cell recruitment [55, 56] and natriuretic response [57] . Moreover, an overexpression of AT2 receptor has been observed during tissue damage [581. In the adult kidney, the AT1 receptor is present in mesangial, tubular and interstitial cells [7, 32, 39] , while the AT2 receptor is more abundant in fetal kidney [59] . In this paper we have observed that rat renal interstitial fibroblasts (NRK49F cell line) possess binding sites for Ang II, mainly of the AT1 receptor subtype, and express the mRNA for this receptor. This AT1 receptor presents a similar Kd to that found other cells, including fibroblasts of different tissues (cardiac and skin) as well as mesangial and vascular smooth muscle cells [33-391- In general, the AT1 receptor is linked to the calcium-phospholipid-dependent signaling pathway. In renal interstitial fibroblasts, we observed that the Ang II receptor is coupled to calcium release, both from intracellular stores and across the membrane, keeping a similar behavior to cardiac fibroblasts and mesangial cells, but different from tubuloepithelial cells and fetal skin fibroblasts In these latter cells, the AT1 receptor stimulates cAMP production, in contrast to other cells in which it is coupled to adenyl cyclase in an inhibitory manner [601.
Several investigators, including ourselves [611, have observed that Ang H induces hyperplasia/hypertrophy in mesangial cells, while it causes only hypertrophy in tubular epithelial cells [7, 181. In this study we have demonstrated that Ang IT caused modification in the cell cycle in growth-arrested fibroblasts (serum-free medium), inducing the entry into G1 phase. Also, after 48 hours of incubation Ang II significantly increased fibroblast proliferation mediated by AT1 receptor. Furthermore, stimulation for one hour with Ang II induced c-fos gene expression, one of the earliest transcriptional events associated with cell growth [44] . Indirect evidence suggested that Ang II could modify the response of interstitial renal fibroblasts. The systemic infusion of Ang II into normal rats markedly up-regulated a-smooth muscle actin expression in the interstitium, indicating that Ang II may promote the phenotypic modulation of fibroblasts or expand the specific population of major fibroblasts [16, 17] . Our results therefore suggest that in renal interstitial fibroblasts, Aug II, via AT1 receptors, activates short-and long-term growth-related metabolic events.
Interstitial fibrosis occurs in progressive renal diseases. The progression to end-stage renal failure is determined more by the degree of tubulointerstitial injury than the extent of glomerular damage. Fibroblasts from human kidneys with interstitial fibrosis proliferate and synthesize more collagen types I, III and V, and FN than fibroblasts from healthy kidneys [621. Several studies suggest that Ang II may be involved in the accumulation of extracellular matrix in the kidney [63] . In this sense, in vivo infusion of Ang II causes interstitial fibrosis, characterized by deposition of collagens and FN [16, 17] . Also, the administration of angiotensin converting enzyme (ACE) inhibitors and AT1 receptor antagonist reduces collagen and FN expression and synthesis in animal models of progressive renal disease [9] [10] [11] [12] . There is, however, no evidence of a direct effect of Ang II on interstitial fibroblasts. Two different renal cells participate in the development of interstitial fibrosis, tubulo-epithelial cells and fibroblasts, being the latter the main effector cell of this process [2] . In cultured proximal epithelial cells Ang II induces hypertrophy and stimulates the synthesis of type IV collagen, but not type I collagen [411. Our in vitro data show that the interaction of Ang II with renal interstitial fibroblasts increased cell proliferation and the steady state levels of extracellular matrix proteins (mainly FN and type I collagen). These results suggest that local Ang II, acting on both cell types, could contribute to interstitial fibrosis, characterized by tubular atrophy, fibroblast proliferation and matrix accumulation.
TGF-f3 plays a key role in the pathogenesis of renal injury, leading to fibrosis and renal dysfunction in several kidney diseases [19] . TGF-13 contributes to extraeellular matrix accumulation by increasing matrix production, inhibiting its degradation and modulating cell-integrin receptors [20] . An interrelationship between Aug II and TGF-/3 has been described [7] . In vivo Ang II infusion increased glomerular TGF-p production [64] , and in vitro several cell types, including mesangial and tubular cells, respond to Ang II stimulation by increasing TGF-13 expression and synthesis [64, 411. Moreover, in experimental models of renal injury, the treatment with ACE inhibitors and AT1 receptor antagonist diminished renal TGF-/3 expression [11, 12] . In this work we have demonstrated that in renal interstitial fibroblasts Ang II, via AT1 receptors, increased TGF-pl mRNA expression. Also, the fact that neutralizing antibody against TGF-f3 abolished the FN synthesis induced by Ang II in these cells suggests that the autocrine production of TGF-13 is involved in Ang 11-induced matrix accumulation.
The effects of Aug II on growth, gene expression and FN production are mediated primarily by AT1 receptor. DUP753 completely blocked Ang II effects, whereas AT2 receptor antagonist did not interfere with these Aug II responses. These results support recent data that AT1 receptor antagonist are as effective as ACE inhibitors in reducing interstitial damage in renal disease [12] , and suggest that this beneficial effect could he due to the modulation of Ang II responses (cell proliferation and synthesis of matrix proteins and TGF-f3) in interstitial fibroblasts.
We further investigated some mechanisms in response to Aug II stimulation in renal interstitial fibroblasts. We have observed that in these cells, AT1 receptors are linked to calcium mobilization by a mechanism dependent of PKC and tyrosine kinase activation. Binding of Ang II to AT1 receptor increases protein tyrosine phosphorylation and activates several protein kinases, such as PKC, MAP kinase, calcium calmodulin-dependent kinase and S6 kinase [42, 43] . Numerous studies suggest an important role for PKC as an intracellular mediator of the effects of some hypertrophic growth stimuli [651, including EN production [481. In this work, we have observed that Ang Il-induced calcium mobilization and EN production was inhibited by staurosporine, a PKC inhibitor, suggesting that activation of PKC is involved in Ang II responses. Specific phosphotyrosine-containing proteins have been identified as substrates for Ang Il-stimulated tyrosine kinases, including PLC-yi [66] and STAT family of transcription factors [67] . Recent studies in vascular smooth muscle cells suggest that many Ang II effects require tyrosine phosphorylation, such as vessel contraction, inositol triphosphate formation, protein synthesis and MAP kinase activity, as shown by the employment of tyrosine kinase inhibitors [43, 68, 69] . In this work, we have shown that Ang lI-induced calcium mobilization and FN synthesis were blocked by genistein, a tyrosine kinase inhibitor. Although the AT1 receptor is a typical G protein-coupled receptor that lacks tyrosine kinase activity, these results suggest that a receptor-associated tyrosine-kinase may be involved in Ang II signaling. All these results contribute to elucidate the role of tyrosine kinases in Ang II actions in renal cells.
Another major finding of our study was that renal interstitial fibroblasts showed constitutive angiotensinogen mRNA, suggesting that those cells could possess intracellular renin-angiotensin system and therefore contribute to local Ang II generation. These data are in agreement with studies on cardiac fibroblasts that present intracellular Ang I, Ang II and ACE immunoreactivity [70] . Although future studies are necessary to determine whether all components of this system, like renin and ACE activity, are present in renal fibroblasts, increasing evidence suggests that these cells could contribute to local Ang II generation. We have also observed that angiotensinogen gene expression was upregulated in response to Ang 11, thus showing a positive feedback regulation. A similar phenomenon has previously been observed in hepatocytes and cardiac myocytes [50, 711 . Activation of the transcription factor NF-KB could be involved in the regulation of angiotensinogen mRNA levels in hepatocytes [72] . Recent data have shown the activation of transcription factors during tissue damage [73] . Also, elevated angiotensinogen mRNA levels have been observed in those situations [74] . In this sense, in a model of immune complex nephritis, we have recently demonstrated an increase in NF-KB activity in renal cortex [75] coincidentally with an increase in cortical ACE activity and an up-regulation of renal angiotensinogen mRNA expression [15] . In addition, we have also demonstrated that Ang II activates NF-KB in cultured glomerular mesangial cells and vascular smooth muscle cells [75, 76] . Therefore, it is reasonable to speculate that Ang Il-induced angiotensinogen gene in renal interstitial fibroblasts could be mediated by activation of NF-KB. All these data suggest that these cells are not only a target of Ang II, but might also contribute to a sustained synthesis of local Ang II, and therefore potentially to further tissue damage.
In summary, in this study we have noted that Ang 11 caused hyperplasia of renal interstitial fibroblasts and increased synthesis of extracellular matrix, via the AT1 receptor type. Furthermore, Ang 11 may initiate a positive-feedback regulation of fibroblasts growth, inducing the expression of TGF-/3l and arigiotensinogen genes. These results suggest that locally increased Ang II generation, by direct interaction with fibroblasts, could contribute to the pathogenesis of interstitial fibrosis.
